Recent Therapeutic Advances in Pituitary Carcinoma
Pituitary carcinoma (PC) is a rare, aggressive malignancy that comprises 0.1–0.2% of all pituitary tumors. PC is defined anatomically as a pituitary tumor that metastasizes outside the primary intrasellar location as noncontiguous lesions in the central nervous system or as metastases to other organ...
Main Authors: | Ian J. Robertson, Timothy A. Gregory, Steven G. Waguespack, Marta Penas-Prado, Nazanin K. Majd |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2023-05-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-22-25 |
Similar Items
-
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
by: G Giuffrida, et al.
Published: (2019-05-01) -
Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
by: Tae Nakano-Tateno, et al.
Published: (2021-03-01) -
Clinical Efficacy of Temozolomide and Its Predictors in Aggressive Pituitary Tumors and Pituitary Carcinomas: A Systematic Review and Meta-Analysis
by: Mei Luo, et al.
Published: (2021-06-01) -
Exploring the Role of Novel Medical Therapies for Aggressive Pituitary Tumors: A Review of the Literature—“Are We There Yet?”
by: Lydia S. Lamb, et al.
Published: (2020-01-01) -
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
by: Cristina Lamas, et al.
Published: (2023-08-01)